Company Filing History:
Years Active: 2009-2012
Title: The Innovative Journey of Inventor Boris Feld
Introduction
Boris Feld is a distinguished inventor based in New Milford, NJ, USA, known for his significant contributions to pharmaceutical innovation. With a total of three patents to his name, Feld has focused on developing novel treatments for viral infections, showcasing his commitment to improving public health through scientific advancements.
Latest Patents
Boris Feld's latest innovations include groundbreaking patents in the field of antiviral treatments. One of his key inventions is related to **2,3-substituted indole derivatives for treating viral infections**. This invention encompasses compositions that comprise at least one 2,3-substituted indole derivative and outlines methods for their use in treating or preventing viral infections or virus-related disorders in patients. Another notable patent focuses on **treatments for Flaviviridae virus infection**, providing methodologies for treating infections caused by viruses of the Flaviviridae family, such as Hepatitis C virus (HCV), by administering an Ara-C homologue to affected hosts.
Career Highlights
Feld has established a notable career at Schering Corporation, where he has been instrumental in the research and development of antiviral medications. His work reflects a robust understanding of virology and the pharmaceutical landscape, positioning him as a leading figure in the fight against viral disorders.
Collaborations
Throughout his career, Boris Feld has collaborated with esteemed colleagues, including Robert Palermo and Bruce A. Malcolm. These partnerships have facilitated innovative research and enhanced the effectiveness of the treatments developed under Feld's guidance.
Conclusion
Boris Feld's contributions to medical innovation, particularly in the realm of antiviral therapies, highlight his role as a key inventor. His ongoing research at Schering Corporation continues to impact the pharmaceutical industry, offering hope for more effective treatment options against viral infections. As he advances his work, the potential for new discoveries remains promising for the future of healthcare.